AstraZeneca says FDA approves drug for rare kidney disease in adults

AstraZeneca said on Wednesday the US Food and Drug Administration granted accelerated approval for its treatment ​for adults with immunoglobulin A nephropathy, a ‌rare kidney disease that can lead to ...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。